HESKA

What HESKA does

Heska Corporation is a US-based companion animal diagnostics company that develops, manufactures, and distributes in-house point-of-care diagnostic instruments, consumables, and digital services for veterinary hospitals and clinics. Its product portfolio centers on the Element Series platform of analyzers covering clinical chemistry (Element DC5X, Element DCX), hematology (Element HT5, Element HT5+ with five-part WBC differential in under 90 seconds), blood gas and electrolytes (Element POC handheld), coagulation (Element COAG+), and immunodiagnostics (Element i+). The portfolio is rounded out by trūRapid point-of-care test kits for vector-borne disease, heartworm, and FIV/FeLV screening, the Allercept IgE-based allergy panel system, the proprietary Nu.Q in-house canine cancer blood test, and the HeskaView telecytology consultation service and cloud-based PIMS software (HeskaView Connect). Underlying technology is conventional clinical chemistry, immunoassay, lateral-flow rapid testing, and digital cytology workflows, with the Nu.Q assay and Allercept panels representing the only in-house veterinary offerings of their kind in the market. The business model is a hybrid of hardware placement (analyzers sold or placed at veterinary practices) and recurring consumables revenue (reagents, test cartridges, rapid test kits, allergy panels), supplemented by licensing/royalty income from technology partners such as VolitionRx. Go-to-market is B2B enterprise field sales targeting veterinary hospitals, clinics, and companion animal practices, with direct ordering via the customerportal.heska.com portal. Heska was acquired by Mars, Incorporated in June 2023 for approximately $1.3 billion and now operates as a private subsidiary within Mars Petcare's Science & Diagnostics division, with products distributed through Antech Diagnostics.

Name

HESKA

Legal name

Antech Diagnostics, Inc.

Website

https://heska.com

Company type

Private

Founded year

1952

Operating status

Acquired

Headcount range

501–1,000 employees

Short description

Heska develops and distributes in-house veterinary diagnostic instruments, consumables, and digital services (Element Series analyzers, trūRapid tests, Nu.Q cancer test, Allercept allergy panels, HeskaView telecytology) to companion animal veterinary hospitals and clinics, now operating as Antech Diagnostics within Mars Petcare following a 2023 acquisition.

Ownership category

akta.pro rank

Product category

Veterinary Diagnostics

NAICS

Veterinary Services (541940)

SIC

Surgical & Medical Instruments & Apparatus (3841), Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers) (HLAMADAI)

akta.pro secondary industries

Veterinary Anatomic Pathology (Histopathology & Cytology) (HLAMADAB), Dermatology & Allergy Drugs (HLAMAEAH), Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology) (HLAMAIAH)

Keywords

• Veterinary diagnostic equipment
• In-house lab analyzers
• Companion animal diagnostics
• Point-of-care testing
• Veterinary immunoassays

Headquarters

HQ city

Loveland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Veterinary Diagnostic Equipment Sales: Sale of in-house diagnostic instruments including Element Series analyzers (chemistry, hematology, blood gas), rapid test kits, and consumables to veterinary practices.
2. Diagnostic Consumables and Reagents: Recurring revenue from sale of test cartridges, reagents, and consumables for installed diagnostic equipment.
3. Licensing and Royalty Arrangements: Revenue from licensing technology to partners such as the Nu.Q Vet agreement with VolitionRx.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Heska develops, manufactures, and distributes in-house veterinary diagnostic instruments, consumables, and software for companion animal healthcare practices. Its portfolio centers on the Element Series analyzers (chemistry, hematology, blood gas, electrolytes, coagulation, fecal/urine, and immunoassay), trūRapid point-of-care test kits, the Nu.Q canine cancer blood test, Allercept IgE-based allergy panels and therapy products, and HeskaView telecytology and Connect practice management software. Products are sold to veterinary hospitals and clinics through Antech Diagnostics within Mars Petcare.

Product overview

Heska is a companion animal diagnostics company that provides an integrated portfolio of in-house diagnostic products and services. The product lineup centers on the Element Series™ platform of analyzers for chemistry, hematology, blood gas, electrolytes, and immunoassay testing, complemented by rapid point-of-care tests (trūRapid™), digital cytology services (HeskaView™ Telecytology), cloud-based practice management software (HeskaView™ Connect), and the proprietary Nu.Q® canine cancer blood test. The Allercept™ IgE-based allergy panels were added through acquisition. These products are distributed through Antech Diagnostics, which operates as part of Mars Petcare's Science & Diagnostics division following Mars Inc.'s acquisition of Heska in 2023.

Differentiator

Problem solved

Functional benefit

Brands

• Element Series: Chemistry, hematology, and blood gas and electrolyte systems, as well as specialty analyzers for immunoassay and coagulation parameters.
• Nu.Q
• Allercept
• trūRapid
• HeskaView

Products and services

• Element AIM™ Automated fecal and urine in-house laboratory analyzer for veterinary practices, positioned as the industry's only automated fecal and urine in-house lab.
• Element COAG+™ Coagulation analyzer for veterinary practices that runs PT and aPTT tests in treatment room, operating room, or cage side settings.
• Element DC5X™ Professional-grade clinical chemistry analyzer for veterinary diagnostics.
• Element DCX™ Clinical chemistry analyzer for veterinary practices, providing simple, fast, and flexible chemistry testing with high accuracy.
• Element HT5+™ Hematology analyzer delivering a true five-part WBC differential plus reticulocytes in 90 seconds for veterinary practices.
• Element HT5™ Hematology analyzer providing a true five-part WBC differential along with RBC and platelet parameters in under 60 seconds for veterinary practices.
• Element i+™ Immunodiagnostic analyzer supporting total T4, cortisol, progesterone, cTSH, cCRP, and the Nu.Q cancer test in veterinary practices.
• Element POC™ Handheld point-of-care blood chemistry, electrolytes, hematology, acid-base, and blood gas analyzer for veterinary practices.
• HeskaView™ Connect Cloud-based Practice Information Management System (PIMS) software for veterinary practice operations and integration with diagnostic instruments.
• HeskaView™ Telecytology Digital cytology consultation service connecting veterinary practices with board-certified clinical pathologists for patient sample evaluation.
• Nu.Q® In-house canine cancer blood test, positioned as the industry's only blood-based cancer screening test for dogs, run on the Element i+ immunodiagnostic analyzer.
• trūRapid™ FIV/FeLV Rapid in-house test kit for detecting Feline Immunodeficiency Virus (FIV) and Feline Leukemia Virus (FeLV) in cats.
• trūRapid™ FOUR Rapid in-house test for canine vector-borne disease screening, covering multiple pathogens in minutes.
• trūRapid™ Heartworm Rapid in-house heartworm detection test for canine screening in veterinary practices.
• Allercept™ IgE-based allergy testing panels and therapy products (shots and drops) for identifying and treating environmental and food allergens in companion animals, acquired as a brand.

Quantifiable outcome

• Rapid diagnostic results - Element HT5 provides five-part WBC differential plus reticulocytes in 90 seconds; Element HT5 in under 60 seconds
• +1 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• VolitionRxcoreTechnology or IntegrationVolitionRx has a Nu.Q Vet agreement with Heska for the distribution and integration of Nu.Q technology in veterinary diagnostics. VolitionRx reported Q1 2026 revenue of $1.0 million driven by deferred revenue recognition from the Nu.Q Vet agreement with Heska, representing 300% year-over-year growth from this partnership.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Virbac: Global animal health company with companion animal diagnostics, pharmaceuticals and nutrition offerings. Competitor in veterinary diagnostics with broader pharmaceutical portfolio similar to Zoetis.
• Zoetis: Largest animal health company globally, offering diagnostics (via legacy Abaxis), pharmaceuticals and biologics. Comparable in companion animal diagnostics space but with a far broader portfolio and larger commercial footprint.

Emerging players

• VolitionRx: Nu.Q Vet licensing partner of Heska, providing the biomarker technology behind the Nu.Q canine cancer test. Directly tied into Heska's product roadmap and revenue via the licensing arrangement.
• Bionote: Korean veterinary diagnostics company with rapid immunoassay and hematology analyzers. Competes in the in-clinic POC space where Heska's Element Series and trūRapid operate.
• Eurolyser: Point-of-care veterinary diagnostic analyzer manufacturer now distributed via Antech (sibling channel). Directly comparable benchtop chemistry/hematology analyzers for in-clinic use.

Direct peers

• Abaxis (Zoetis Diagnostics): Acquired by Zoetis in 2018, Abaxis's VetScan line of in-clinic chemistry, hematology and immunoassay analyzers directly competes with Heska's Element Series in veterinary practice channels.
• Antech Diagnostics: Reference laboratory and now sibling unit within Mars Petcare's Science & Diagnostics division. Operates the same end customer (veterinary practices) with complementary reference lab and imaging services that overlap Heska's in-house diagnostics business.
• IDEXX Laboratories: Dominant veterinary diagnostics company offering in-clinic analyzers, reference lab services, and rapid tests across companion animals. Closest direct competitor to Heska's Element Series and trūRapid portfolio, with overlapping channels and product breadth.

Regional players

• Woodley Equipment: UK-based distributor and supplier of point-of-care veterinary diagnostic equipment and consumables. Comparable as a channel competitor in veterinary POC diagnostics, primarily in European markets.

Others

• scil animal care: European veterinary diagnostics and imaging company acquired by Heska in 2020 and now part of the Mars Petcare Science & Diagnostics division. Provides adjacent hematology/chemistry and imaging product lines via shared distribution.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Heska
• LinkedInlinkedin.com/company/heska-corporation
• Instagraminstagram.com/antech_diagnostics
• Xx.com/heskacorp

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A6 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HESKA